Abstract
Objectives : This study was designed to evaluate effects of 'Soyeum' on cancer patients accompanied by pain. Materials and Methods : We retrospectively analyzed the medical records of 9 patients accompanied by pain who had been injected with 'Soyeum' for over 14 days continuously in East-West Cancer Center of Oriental Hospital of Daejeon University from June 2002 through august 2002. Results : The statistical significance between the pre-treatment and post-treatment results (Changes of Cytokine Level, QOL, BPQ and Pain relief after pain management) were analyzed. Analysis of cytokines (IL-12, IFN- ) level showed that the percentage of increase of lL-12 is $60\%$, IFN- is $60\%$. Analysis of QOL showed that the percentage of maintenance and improvement is $77.8\%$. $55.5\%$ of the patients reported a 'worst pain' intensity score of 3 or greater, $44.5\%$ reported a 'least pain' intensity score of 2 or greater, and $66.7\%$ reported 'average pain' intensity score of 2 or greater. $33.3\%$ of the patients were in pain at the time of interview and $22.2\%$ had a current intensity score of 2 or greater. Analysis of pain relief after pain management showed that the percentage of pain relief score of 2 and 3 is $55.6\%$. The data was expressed as Mean SE by using descriptive statistics. Statistical significance examined by using paired t-test. Conclusions : It is suggested that 'Soyeum' has effects on pain of cancer patients, also expected that 'Soyeum' is useful to improve immunoactivity and for cancer patients
